USANA Health Sciences, Inc.
USNA
$27.27
-$0.28-1.02%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.12M | 34.90M | 42.03M | 54.34M | 55.08M |
| Total Depreciation and Amortization | 31.29M | 27.39M | 22.23M | 21.22M | 20.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.49M | 7.52M | 9.74M | 13.39M | 13.54M |
| Change in Net Operating Assets | -10.88M | -11.01M | -13.00M | -7.72M | -15.51M |
| Cash from Operations | 63.02M | 58.79M | 60.99M | 81.23M | 73.93M |
| Capital Expenditure | -12.03M | -9.68M | -10.07M | -15.60M | -14.65M |
| Sale of Property, Plant, and Equipment | 61.00K | 61.00K | 64.00K | 66.00K | 5.00K |
| Cash Acquisitions | -203.34M | -203.34M | -203.34M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.00K | 53.00K | 255.00K | 255.00K | 255.00K |
| Cash from Investing | -215.51M | -212.90M | -213.09M | -15.27M | -14.39M |
| Total Debt Issued | 24.60M | 23.15M | 23.69M | 1.48M | 1.48M |
| Total Debt Repaid | -24.59M | -1.47M | -1.47M | -1.47M | -1.48M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -29.85M | -14.65M | -12.67M | -12.73M | -24.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -379.00K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -30.23M | 7.03M | 9.55M | -12.72M | -24.28M |
| Foreign Exchange rate Adjustments | 1.67M | -1.67M | -6.19M | 4.68M | -3.02M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.05M | -148.74M | -148.74M | 57.92M | 32.23M |